Thursday, August 31, 2017

Do Women Need Their Own Viagra? Very common. get Viagra or Cialis $14.79 at 888 /500 / 4597 jersey & York Health Mad

Some argue that a female sexual-dysfunction drug is a matter of equality among the sexes. Others say it creates a medical problem where none exists.'''                                                        Image result for Do Women Need Their Own Viagra?                                                  “Aren’t women’s sexual needs as important as erectile dysfunction in men?” To hear one side tell it, that’s the central issue in the debate over what’s known as “pink Viagra,” a sexual-dysfunction drug for women. Health organizations and the pharmaceutical industry say the absence of a female drug is a pressing problem that affects millions of relationships in the U.S. every year—and is the result of decades of inequality in scientific research. On the other hand, some researchers believe these groups, along with the drug industry, are creating a medical need where one doesn’t really exist, and that there isn’t a double standard at play in rejecting the latest female drug, flibanserin. As they see it, pink pill advocates are co-opting the language of equality, while drug marketers ignore the complexities of female sexual dysfunction, and how best to treat it.

One of the difficulties in this debate is the interplay between biological and psychological aspects of a person’s sex drive. How men and women get “turned on” is vastly complicated—and erectile dysfunction drugs and flibanserin work differently. Viagra, for example, doesn’t cause a man to want sex. The drug only works if a man already feels aroused, by helping blood flow into the erectile tissue of his penis. Flibanserin, on the other hand, corrects an imbalance in the levels of certain neurotransmitters, such as dopamine and serotonin, thought to regulate sexual excitement and inhibition.
Image result for Do Women Need Their Own Viagra?On October 27, the Food and Drug Administration invited women to a public summit on female sexual dysfunction—and what the medical community should do about it. The FDA heard directly from women about losing their desire for sex and the daily experience of living with, according to the agency’s invitation, the most common form of sexual dysfunction for women: female sexual interest/arousal disorder, or FSIAD. The following day, the FDA held a scientific workshop on the challenges of diagnosing and measuring FSIAD, reigniting a public debate about whether there’s a need for female dysfunction drugs in the first place. Leonore Tiefer, clinical associate professor of psychiatry at New York University’s School of Medicine and founder of the New View Campaign, which challenges the medicalization of sex, co-wrote a Los Angeles Times op-ed in which she claims women at the hearings “appeared to have been coached to demand drug solutions,” and insisted they had “no non-medical problems” that may affect their sex drive. At the same time, numerous medical groups, such as the Society for Women’s Health Research, the American College of Nurse-Midwives, and the Association of Reproductive Health Professionals, strongly urged Dr. Janet Woodcock, director of the FDA’s center for drug evaluation and research, to approve a treatment for female sexual dysfunction.
It’s unclear how prevalent desire issues are among women to begin with. Medical sites and the media present vastly different pictures of the problem, some putting it at around 10 percent of the population (16 million people in the U.S.), others putting it closer to 40 percent of women suffering from some kind of sexual dysfunction.

The first figure comes from a 2008 study, published in the Journal of Obstetrics and Gynecology, which surveyed more than 30,000 women. Researchers found that 12 percent of respondents had a sexual problem and felt distress over it. In a healthcare setting, doctors can struggle with what constitutes female sexual dysfunction—a catchall term for women who have trouble with interest or arousal, who experience pain during sex, or have difficulty achieving orgasm—and somebody who reports a lack of a desire may not be concerned about it. It’s also difficult to separate biological factors from emotional and social ones. But a woman isn’t diagnosed with FSAID or considered a candidate for medical treatment if her lack of interest isn’t causing her distress.
The second statistic comes from a 1999 study in the Journal of the American Medical Association, which found that 43 percent of the 1,749 women sampled (as opposed to 31 percent of men) had experienced some form of broadly-defined sexual dissatisfaction, including lack of desire and arousal, in the past two months. But researchers noted that the women surveyed were more likely to suffer from sexual dysfunction if they had unsatisfying personal experiences and relationships—something a pill can’t solve. And while the FDA appears to be of the opinion that female desire disorder (a woman’s body responds to sex but she has no interest in it) and female arousal disorder (a woman wants to have sex, but her body doesn’t seem to respond) can be lumped into one diagnosis, FSAID, most of the letters in support of a female dysfunction drug and many of the scientific studies refer to a different diagnosis: Hypoactive Sexual Desire Disorder (HSDD), which deals with a woman’s “interest level” in sex, but not necessarily her physiological responses to stimulation.

Last fall, when the FDA denied Sprout Pharmaceuticals’ application to market flibanserin, a drug for low female desire, one of the most prominent women’s groups, the National Organization of Women, met with the agency to voice concern about the decision. Four U.S. congresswomen blamed institutionalized sexism, writing the government in support of a drug for female sexual dysfunction. According to a 2007 Johns Hopkins study, published in the American Journal of Medicine, 18 million men have erectile dysfunction—not significantly larger, from a medical standpoint, than the 16 million women who may suffer from a lack of desire and feel distress.
The advocacy group Even The Score argues that the FDA has systematically discounted female sexual dysfunction. Viagra, the first male sexual-dysfunction drug, was approved in the U.S. in 1998, and according to Susan Scanlan, chair of Even The Score, men now have 26 drug options for sexual dysfunction—while women have none. “Women shouldn’t be shamed for having this condition. They should be listened to and helped,” said Scanlan, who believes the recent FDA meetings represent the first step towards “a meaningful solution.”
In addition to nonprofit groups such as Black Women’s Health Imperative and the Center for Health and Gender Equality, Even The Score also lists Sprout Pharmaceuticals—with other drug companies—as supporters on its website.
“Even The Score is a marketing tactic that masquerades as some kind of feminist patient group, but it’s a gimmick,” said Tiefer, who has been vocal at FDA hearings about her opposition to flibanserin and doubts there is a pressing medical need for a female sexual-dysfunction drug. Many couples have difficulties when it comes to a range of lifestyle concerns, from in-laws and children to personal finances and work balance, she explained. But that doesn’t mean one of them has a “biological inadequacy” in any of those areas. So when a couple has an asymmetrical level of desire, why does one of them necessarily suffer from a medical problem? Perhaps, she posits, it’s the “world of cell phones, deadlines, and multitasking” that places stress on couples’ sex lives, not a chemical deficiency. “Having been a sex therapist and a psychologist, I’ve heard from hundreds upon hundreds of people,” said Tiefer, who blames modern life and the societal pressures women face to look a certain way, in part, for creating desire asymmetry among couples.
Illustrating the tension between marketing and medical science, a recent articlein Marie Claire recounts a Baltimore woman’s experience with flibanserin. Writer Virginia Sole-Smith reports that “Cara” is in her late 30s and a development director for a non-profit, with two young children. Her “sex drive dropped dramatically and never rebounded” after the birth of her first baby. A few weeks into the study, however, she claims a drastic change, planning a mid-workday rendezvous with her husband, leaving a trail of clues for him:
In the first envelope, Ryan found instructions to pick up oysters during his lunch break. Envelope two asked him to swing by a wine store. Number three only said "12 p.m.," along with the name of a local hotel. "I met him at the door wearing only heels," says Cara now. "Building that anticipation all morning was incredibly sexy. Things hadn't been that hot between us in years."
Later, Sole-Smith discloses that she met Cara through a publicist for the drug’s manufacturer and that Cara “posted unusually good results for [her] drug trial.” To readers, Cara’s experience with flibanserin might imply that a woman who doesn’t meet her husband on her lunch break, naked, suffers from low desire. And when it comes to sexuality, there’s already a good deal of insecurity about what is normal, explained Jennifer Fishman, assistant professor in biomedical ethics at McGill University. For both men and women, she said, drug companies often promote an unattainably high ideal of arousal.
With the growth of direct-to-consumer pharmaceutical advertising, there’s been a strong drive to push long-term medications on both men and women, according to Barbara Mintzes, associate professor in the School of Population and Public Health at the University of British Columbia in Vancouver. Unlike Viagra, for example, flibanserin is taken daily, not only in anticipation of sexual activity. Viagra addresses blood flow, while flibanserin works on the chemicals in a woman’s brain. Mintzes, who is also the co-author of Sex, Lies and Pharmaceuticals, believes that women’s sexual difficulties are being repackaged as a new disorder. “It’s not a planned conspiracy against women,” she clarified. “But the aim is to sell a product.” Drug companies see a large marketing opportunity in defining less interest in sex as a medical symptom and leaving a woman’s feelings and relationship circumstances out of the picture, according to Mintzes—not unlike what happened with Viagra advertising. “Male drugs had very stereotyped images of masculinity,” she said, “and not even a hint that a man’s emotions might affect his sexuality.”
In contrast are healthcare professionals who believe some women’s low sexual desire will rebound only with drug treatment. Bat Sheva Marcus, clinical director of New York’s Medical Center for Female Sexuality, assesses physical and psychological causes of women’s sexual issues and treats hundreds of women seeking to improve their sexual experience. Marcus believes in addressing all the sociological and psychological issues about desire and functioning, but also thinks that completely closing off the avenue of drug treatment would be “ignorant and cruel.” As she puts it: Personal distress is not a social construction. “For women, the most vulnerable part of the sexual response is probably desire,” Marcus explained. “A woman’s desire can shut off in a moment, for an evening, weeks, months, or a year. And it’s a problem if it bothers her.” Marcus also cautions about merging desire (interest) and arousal (a body’s physical reaction to sexual activity) disorders under one umbrella diagnosis, FSIAD. While the problems could be related for some women, she argues that from a clinical standpoint, the two are distinct.
In fact, a string of studies provides evidence of a neurological basis for low desire that might be helped by a drug like flibanserin, which was first developed as an anti-depressant. A small 2009 functional MRI study, published in Neuroscience, compared 20 females with no history of sexual dysfunction to 16 women with low desire levels and found the two groups exhibited different brain activity when presented with sexually explicit videos. In 2013, researchers once again used neuroimaging patterns to compare the brain regions that are activated in pre-menopausal women with and without a diagnosis of HSDD. They also saw significant differences between the two groups, specifically in the area of the brain responsible for memory encoding/retrieval and self-monitoring.
“Unfortunately, there has been a steady and concerted effort to undermine this condition,” said Cindy Whitehead, president and chief operating office of Sprout Pharmaceuticals. “The narrative is that it’s all in a woman’s head. But that’s based o opinion and imposed judgment.” According to Whitehead, sexual desire disorders have been medically recognized since 1977, the era of Masters and Johnson, and even after years of research and evolved understanding about female sexuality, there’s still no treatment for women. “No drug works for every person,” she explained. “But science has given us our answer and it’s time that the narrative about female sexual dysfunction shift to respect not only the data, but the women who are living with this. ” Whitehead also clarifies that a woman is a candidate for medical treatment, only if she has low desire, feels distress about it, and is in a healthy relationship, so any social or emotional issues have been ruled out beforehand.
Unlike many current medical controversies, the debate over a female sexual dysfunction drug may see some resolution soon. Flibanserin will be resubmitted to the FDA in the first quarter of 2015, with a decision expected six months later.

New Report Shows Viagra Could Help Women with Bladder Infections Very common. get Viagra or Cialis $14.79 at 888/500/4597 jersey & York Health Mad

In interstitial cystitis, also known as painful bladder syndrome, the delicate lining of the bladder is inflamed, causing pain and a sense that the bladder is full even when it isn't.
In interstitial cystitis, also known as painful bladder syndrome, the delicate lining of the bladder is inflamed, causing pain and a sense that the bladder is full even when it isn’t.
Known best as the active ingredient in the pioneering impotence drug Viagra, sildenafil continues to show its versatility. In a recent Chinese research study, the compound appeared to ease the symptoms of interstitial cystitis, or IC, a hard-to-cure bladder infection seen most commonly in women.
This is just the latest in a string of studies purporting to show that sildenafil in varying doses can be helpful in treating a number of diseases and conditions other than impotence. In an Italian study, sildenafil improved cardiac function in patients with early-stage heart failure, and it also appeared to prevent thickening of the cardiac muscle, which can compromise the heart’s effectiveness.
Also marketed as Revatio, sildenafil in 2005 got the FDA’s seal of approval as a treatment for pulmonary arterial hypertension, a life-threatening form of high blood pressure that targets the tiny arteries that supply the lungs.
Chinese Study
In its study of sildenafil as a treatment for interstitial cystitis, a team of researchers at China’s Wenzhou Medical University found that the compound significantly reduced symptoms in women with the chronic bladder condition.
While its cause remains unknown, interstitial cystitis — also known as painful bladder syndrome — is a chronic condition that causes bladder pressure and pain. Ranging from mild discomfort to severe, IC’s pain sometimes is more generalized, affecting the entire pelvic region.
As explained at, the bladder is a hollow, balloon-like organ designed to store urine. Under normal conditions, the bladder expands as it fills with urine and, when full, signals the brain that it’s time to urinate. In IC, however, those signals somehow get scrambled. As a result, IC patients feel a much more frequent need to urinate, even when the bladder is far from full.
The Pain of Cystitis
The pain associated with IC comes from the condition’s characteristic inflammation of the bladder’s lining, which can cause scarring and may eventually lead to a stiffening of the bladder. According to, this inflammation causes pinpoint bleeding in the bladder’s lining in almost 90 percent of all IC cases. In extreme cases, ulcers or sores will develop in the delicate tissues lining the bladder.
A Chinese study found that a 25-milligram daily dose of sildenafil helped to relieve the symptoms of interstitial cystitis.
A Chinese study found that a 25-milligram daily dose of sildenafil helped to relieve the symptoms of interstitial cystitis.
The Chinese study evaluated the effects of sildenafil on symptoms of IC in women who had no ulceration of the bladder lining. Researchers assembled a study group of 48 women, all of whom had received a clinical diagnosis of IC.  Half of the women got a daily dose of 25 milligrams of sildenafil (roughly half the minimum dosage for treating impotence in men). The other half got a placebo.
Over the next three months, researchers evaluated the women for frequency and urgency of urination and incidence of urgent nighttime urination, or nocturia. Overall, the efficiency of sildenafil treatment was 62.5 percent, according to the Chinese study, which was published in the July 2014 issue of ¨Urology.¨
Can Strike at Any Age
According to WebMD, anyone can develop IC, although it is far more common in women than in men. It can strike at any age but is most commonly diagnosed among the middle-aged. It also seems to appear most frequently in people who have other pain-related conditions, such as fibromyalgia and irritable bowel syndrome.     Once thought to be confined to a relatively small segment of the U.S. population, IC affects roughly 3 to 6 percent of all American women over the age of 18, according to data presented at the 2009 annual meeting of the American Urological Association. Funded by the National Institutes of Health, the RAND Interstitial Cystitis Epidemiology (RICE) survey suggests that IC could affect anywhere from 3.4 million to 7.9 million American women.
Survey’s Findings Welcomed
Barbara Gordon, then-executive director of the Interstitial Cystitis Association, welcomed the RICE study, saying, ¨It is gratifying to see such a rigorous study that provides us with an accurate picture of how many American women are living with IC.¨
Of the Chinese study and its findings about sildenafil’s potential as a treatment for IC, consultant urologist Robyn Webber, M.D., pointed out to that the study’s ¨number of patients . . . was small, and the findings need to be reproduced with bigger numbers.” However, she said that ¨if the results do hold up, it could potentially offer hope to some patients.¨
Just how sildenafil eases the symptoms of IC is unclear. However, some speculate that in increasing blood flow to the pelvic region, sildenafil relaxes muscles in the bladder. With the relaxation of the bladder’s muscles, the urge to urinate is reduced.
Sildenafil, the active ingredient in Viagra, seems to be effective in treating a number of other ailments, including interstitial cystitis.
Sildenafil, the active ingredient in Viagra, seems to be effective in treating a number of other ailments, including interstitial cystitis.
Optimizes Blood Flow
Sildenafil’s effects on blood flow are key to its success in the treatment of impotence. The vast majority of men with erection problems can trace their impotence to diminished blood flow to the penis. Sildenafil and the other PDE5 inhibitors that have followed work by temporarily blocking the effects of the phosphodiesterase-5 enzyme, which interferes with erectile function.
Erectile function actually originates in the brain as feelings of sexual desire. Those feelings trigger the brain to send a flood of nitric oxide to the pelvic region. Among the many chemical reactions set in motion by this flood of nitric oxide is the creation of a substance known as cyclic guanosine monophosphate, or cGMP. To facilitate the flow of blood into the penis’s spongy erectile tissues, thus creating an erection, cGMP relaxes the smooth muscles that line the blood vessels of the pelvic region.
The primary role of the PDE5 enzyme is to break down cGMP. However, if it starts doing its job before cGMP has boosted blood flow to the penis, getting an erection is much more difficult, if not impossible.                              

Health Benefits of Apple Cider Vinegar

A few weeks ago when I was recapping my experience with the Eat Clean Challenge, I mentioned apple cider vinegar and how I was hooked on drinking it daily. Several people seemed interested in the apple cider vinegar (ACV) drink I’ve been drinking so I figured I would do a post on it.
Apple Cider VinegarI first learned about the benefits of ACV through Tosca Reno’s Eat Clean Diet and the Tone It Up nutrition plan. Both plans recommend adding ACV into your daily diet. Tosca recommends mixing 2 Tablespoons of raw, unfiltered ACV into a glass of water and the Tone It Up gals recommend a drink recipe called the Meta-D which has ACV, water and a few other ingredients.
I will warn you that ACV is pretty potent and it does take a little getting used to. Many people recommend adding a splash of fruit juice, honey or stevia to the ACV + water mixture to help make it more palatable.

Here are a few common questions around ACV…
What type of Apple Cider Vinegar should I use?
Only use raw organic ACV has the ‘mother’ of the vinegar. The ‘mother’ is made up of strand-like enzymes of connected protein molecules with living nutrients and bacteria, similar to the ‘mother’ that’s in Kombucha. Clear vinegar is processed and doesn’t have any of the benefits that raw ACV has. There are different brands out there but I useBragg’s Apple Cider Vinegar, which I find at my local organic market or Whole Foods.
Be sure to dilute ACV before applying it to your skin or drinking. It is very acidic and can damage the tooth enamel and the tissues of your throat, mouth or skin.
What are the benefits of Apple Cider Vinegar?
  • Rich in potassium, a mineral that is often times lacking in adult diets. This mineral is key for growth, building muscles, transmission of nerve impulses, heart activity etc. It also helps to prevent brittle teeth, hair loss and runny noses.
  • Rich in acetic acid. This acid is said to slow the digestion of starch which can help to lower the rise in glucose that commonly occurs after meals.
  • Rich in ash which gives ACV its alkaline property. This aids your body in maintaining proper pH levels for a healthy alkaline state. (It is particularly important if you drink a lot of coffee or wine.)
  • It can help regulate blood pressure and reduce bad cholesterol.
  • Rich in malic acid which gives ACV its anti-viral, anti-bacterial and anti-fungal properties.
  • May help improve bowel irregularity and helps to remove toxins from the body at a faster rate.
  • It can help clear up skin conditions and blemishes.
  • ACV helps with weight loss by breaking down fats so that your body can use them rather than store them.
  • A few lab studies have found that ACV may be able to kill cancer cells or slow their growth.
Have you noticed any changes in your body since drinking Apple Cider Vinegar daily?
It’s hard for me to tell if the ACV drink is working wonders on my body and helping in ALL the ways I mentioned above, however I do know that my complexion has been really clear since I’ve started taking it and I crave the ACV drink every day now. In the morning I make my drink in a blender/shaker bottle and take it to work with me. I’ll have it in mid-morning or after lunch with my afternoon snack. It definitely helps to keep me feeling full and less hungry.
How much do you drink and how do you prepare it?
I drink 2 Tablespoons a day, in the morning, and I usually use this recipe.
If you’re interested in learning more about ACV here are a few links that are worth checking out:

Wednesday, August 30, 2017

Erectile dysfunction Also called: ED, impotence

Occurs when a man can't get or keep an erection firm enough for sexual intercourse.
Very common. get Viagra or Cialis $14.79 at 888/500/4597 jersey & York Health Mad  Image result for Erectile dysfunction
More than 3 million US cases per year
Treatable by a medical professional
Usually self-diagnosable
Lab tests or imaging rarely required
Chronic: can last for years or be lifelong
Erectile dysfunction can be a sign of a physical or psychological condition. It can cause stress, relationship strain, and low self-confidence.
The main symptom is a man's inability to get or keep an erection firm enough for sexual intercourse.
Patients suffering from erectile dysfunction should first be evaluated for any underlying physical and psychological conditions. If treatment of the underlying conditions doesn't help, medications and assistive devices, such as pumps, can be prescribed.
Ages affected
Very rare
Very rare
Very common
Consult a doctor for medical advice